J R Eckardt

发表

Initial phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, using the modified continual reassessment method for dose escalation.

H. Burris, F. A. Dorr, F A Dorr, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.